About the Salivary Gland Cancer Session
Salivary gland cancer, though relatively rare, presents unique challenges in cancer research. These cancers originate in the salivary glands, responsible for producing saliva. Due to their location and diverse histological types, diagnosing and treating salivary gland cancers require specialized expertise. Research efforts focus on understanding the genetic and molecular mechanisms driving these cancers to develop targeted therapies. Additionally, advancements in imaging techniques aid in early detection and precise treatment planning. Despite progress, challenges such as limited treatment options for advanced stages and potential side effects from surgery or radiation therapy persist. Collaborative research endeavors aim to improve outcomes for individuals facing this complex disease, highlighting the importance of multidisciplinary approaches in cancer care.
Topics Covered in Salivary Gland Cancer
Mucoepidermoid Carcinoma
Adenoid Cystic Carcinoma
Salivary Duct Carcinoma
Histologic Grading
Gene Fusions
Androgen Receptor Targeting
Related Scientific Sessions at CIOC 2027
Why Attend the Salivary Gland Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Salivary Gland Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Salivary Gland Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Salivary Gland Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Salivary Gland Cancer Conference 2027 — FAQs
What is the Salivary Gland Cancer track at CIOC 2027?
The Salivary Gland Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Salivary Gland Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Salivary Gland Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Salivary Gland Cancer are all welcome — whether presenting or attending.
Can I present my research in the Salivary Gland Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Salivary Gland Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Salivary Gland Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.